Search alternatives:
_ we » _ e (Expand Search), _ fe (Expand Search)
a a » a al (Expand Search), a la (Expand Search)
decrease » decreased (Expand Search), increase (Expand Search)
rats » rates (Expand Search), rate (Expand Search), rcts (Expand Search)
Showing 1 - 3 results of 3 for search '(( 5 a decrease ) OR ((((( _ we decrease ) OR ( _ rats decrease ))) OR ( a a decrease ))))~', query time: 0.08s Refine Results
  1. 1
    Disrupting the α-synuclein-ESCRT interaction with a peptide inhibitor mitigates neurodegeneration in preclinical models of Parkinson’s disease

    Disrupting the α-synuclein-ESCRT interaction with a peptide inhibitor mitigates neurodegeneration in preclinical models of Parkinson’s disease by Satra Nim (11540447)

    Published 2023
    Save to List
    Saved in:
  2. 2
    Rhus coriaria L. (Sumac) Demonstrates Oncostatic Activity in the Therapeutic and Preventive Model of Breast Carcinoma

    Rhus coriaria L. (Sumac) Demonstrates Oncostatic Activity in the Therapeutic and Preventive Model of Breast Carcinoma by Peter Kubatka (11008854)

    Published 2020
    “…In treated rat carcinomas, we found significant caspase-3, Bax, and Bax/Bcl-2 expression increases; on the other side, a significant down-regulation of Bcl-2, Ki67, CD24, ALDH1, and EpCam expressions and MDA levels. …”
    Save to List
    Saved in:
  3. 3
    Small molecule inhibitors of α-synuclein oligomers identified by targeting early dopamine-mediated motor impairment in C. elegans

    Small molecule inhibitors of α-synuclein oligomers identified by targeting early dopamine-mediated motor impairment in C. elegans by Kevin S. Chen (9201767)

    Published 2021
    “…We found that treatment with rifabutin reduced nigrostriatal dopaminergic neurodegeneration due to α-synuclein in a rat model.…”
    Save to List
    Saved in:

Search Tools: